Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights
-
Mitch Gould’s Memoir The Blonde, the Ferrari and the Kwan To Be Included in Celebrity “Everyone Wins” Nominee Gift Bags
-
NMG Completes Acquisition of Brownfield Site in Bécancour to Deploy its Active Anode Material Production for Panasonic Energy
-
Manchester United Plc Reports Second Quarter Fiscal 2026 Results
-
CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA®
-
Balchem Corporation to Participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026
-
Deep Fission Nuclear Signs Fuel Deal with Urenco USA
-
Tailor Publishes 2026 Retail Tech Conference Guide for Operators
-
Kantar Media Rebrands as Fifty5Blue, Marking a Decisive Step Forward in Audience Measurement
-
Grounded Lithium Spuds First Oil and Gas Well, Advancing Near-Term Cash Flow Strategy
-
Yelp Releases 2025 Trust & Safety Report
-
Marsh Appoints Peter Harrison to Its Board of Directors
-
Angel Oak Mortgage REIT, Inc. Reports Fourth Quarter and Fiscal Year 2025 Financial Results
-
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026
-
Dmitry Shubov Consulting Attends Startups & Operators Pitch Night — Dubai, Connecting With Founders
-
Charles River Laboratories Provides Update on Planned Divestitures
-
Bidgely Named Top 10 Grid Edge Innovator of 2025 by Darcy Partners
-
Energea Launches LATAM Portfolio with $100 Million Commitment in Colombia
-
IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities
-
Via Establishes Mayors Council to Advance Transit Innovation in Cities Across the US
-
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
-
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
-
Relation Insurance Acquires Thorn Creek Insurance Services Inc.
-
BreezeBio (Formerly GenEdit) Announces Series B Financing to Advance Internal Pipeline of Precision Genetic Medicines
-
Nasdaq Raises Medium‑Term Revenue Outlook and Outlines Strategy for Its Next Phase of Scalable Growth at 2026 Investor Day
-
Amarin Reports Fourth Quarter and Full Year 2025 Financial Results
-
Iron Mountain to Present at Upcoming Financial Conferences
-
ODDITY Tech Reports Record Full Year 2025 Results
-
Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PE
-
Dmitry Shubov Consulting Attends Startups & Operators Pitch Night — Dubai, Connecting With Founders
-
Photronics Reports First Quarter Fiscal 2026 Results
-
Ovid Therapeutics to Participate in Upcoming Investor Conferences
-
Amplify CWP International Enhanced Dividend Income ETF (IDVO) Surpasses $1 Billion in Assets
-
Istios Health Expands into Virtual Nephrology Care, Announces Strategic Partnership with Penn Highlands Healthcare
-
Breakthrough Shown to Cut Dementia Risk, Now Found to Help Repair Brain Injuries
-
Gray Media To Launch New Daily Program Aging Untold
-
Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences
-
TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
-
Axsome Therapeutics to Participate in Upcoming Investor Conferences
-
At Joint Veterans’ Affairs Hearing, Blue Star Families’ Dr. Lindsay Knight Highlights Transition Risks and Evidence-Based Suicide Prevention Solutions
-
Aquestive Therapeutics to Participate in Upcoming March Investor Conferences
-
GXO announces partnership with Hunkemöller in the Netherlands
-
OTC Markets Group Welcomes RFA Financial Inc. to OTCQX
-
Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
-
Balchem Corporation to Participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026
-
Aktsiaselts Infortar Investor Webinar introducing the results of the Q4 2025
-
BIO-Europe Spring® 2026 Charts the Future of Life Sciences from Lisbon’s Shores
-
George Medicines advances its global commercial strategy for GMRx2 with an exclusive licensing agreement with Orient EuroPharma in Southeast Asia
-
Immunocore reports fourth quarter and full year 2025 financial results and provides a business update
-
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients

